Merck and Co Inc said it has opened
a new 80 mln dlr research facility at its Rahway, N.J.,
headquarters.
    The company said researchers in the new building will be
involved in research on MK-906 for reducing the size of
enlarged prostate glands, an agent to promote wound healing the
leukotiene substances linked to asthma and arthritis, new
vaccines made by genetic engineering, fermentation broths and
safe and cost-effective ways of producing new drugs.
 Reuter
&#3;